|
1
|
Skalny AV, Timashev PS, Aschner M, Aaseth J, Chernova LN, Belyaev VE, Grabeklis AR, Notova SV, Lobinski R, Tsatsakis A, Svistunov AA, Fomin VV, Tinkov AA, Glybochko PV. Serum Zinc, Copper, and Other Biometals Are Associated with COVID-19 Severity Markers. Metabolites 2021; 11:metabo11040244. [PMID: 33920813 PMCID: PMC8071197 DOI: 10.3390/metabo11040244] [Citation(s) in RCA: 50] [Impact Index Per Article: 16.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2021] [Revised: 03/29/2021] [Accepted: 04/07/2021] [Indexed: 12/13/2022] Open
Abstract
The objective of the present study was to evaluate of serum metal levels in COVID-19 patients with different disease severity, and to investigate the independent association between serum metal profile and markers of lung damage. The cohort of COVID-19 patients consisted of groups of subjects with mild, moderate, and severe illness, 50 examinees each. Forty-four healthy subjects of the respective age were involved in the current study as the control group. Serum metal levels were evaluated using inductively-coupled plasma mass-spectrometry. Examination of COVID-19 patients demonstrated that heart rate, respiratory rate, body temperature, C-reactive protein levels, as well as lung damage increased significantly with COVID-19 severity, whereas SpO2 decreased gradually. Increasing COVID-19 severity was also associated with a significant gradual decrease in serum Ca, Fe, Se, Zn levels as compared to controls, whereas serum Cu and especially Cu/Zn ratio were elevated. No significant group differences in serum Mg and Mn levels were observed. Serum Ca, Fe, Se, Zn correlated positively with SpO2, being inversely associated with fever, lung damage, and C-reactive protein concentrations. Opposite correlations were observed for Cu and Cu/Zn ratio. In regression models, serum Se levels were inversely associated with lung damage independently of other markers of disease severity, anthropometric, biochemical, and hemostatic parameters. Cu/Zn ratio was also considered as a significant predictor of lower SpO2 in adjusted regression models. Taken together, these findings demonstrated that metal metabolism significantly interferes with COVID-19 pathogenesis, although the causal relations as well as precise mechanisms are yet to be characterized.
Collapse
Affiliation(s)
- Anatoly V. Skalny
- World-Class Research Center “Digital Biodesign and Personalized Healthcare”, IM Sechenov First Moscow State Medical University (Sechenov University), 119435 Moscow, Russia; (A.V.S.); (P.S.T.); (M.A.); (J.A.); (L.N.C.); (V.E.B.); (A.R.G.); (S.V.N.); (R.L.); (A.T.); (A.A.S.); (V.V.F.); (P.V.G.)
- Laboratory of Medical Elementology, KG Razumovsky Moscow State University of Technologies and Management, 109004 Moscow, Russia
| | - Peter S. Timashev
- World-Class Research Center “Digital Biodesign and Personalized Healthcare”, IM Sechenov First Moscow State Medical University (Sechenov University), 119435 Moscow, Russia; (A.V.S.); (P.S.T.); (M.A.); (J.A.); (L.N.C.); (V.E.B.); (A.R.G.); (S.V.N.); (R.L.); (A.T.); (A.A.S.); (V.V.F.); (P.V.G.)
- Chemistry Department, Lomonosov Moscow State University, 119991 Moscow, Russia
- Department of Polymers and Composites, N.N. Semenov Institute of Chemical Physics, 119991 Moscow, Russia
| | - Michael Aschner
- World-Class Research Center “Digital Biodesign and Personalized Healthcare”, IM Sechenov First Moscow State Medical University (Sechenov University), 119435 Moscow, Russia; (A.V.S.); (P.S.T.); (M.A.); (J.A.); (L.N.C.); (V.E.B.); (A.R.G.); (S.V.N.); (R.L.); (A.T.); (A.A.S.); (V.V.F.); (P.V.G.)
- Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
| | - Jan Aaseth
- World-Class Research Center “Digital Biodesign and Personalized Healthcare”, IM Sechenov First Moscow State Medical University (Sechenov University), 119435 Moscow, Russia; (A.V.S.); (P.S.T.); (M.A.); (J.A.); (L.N.C.); (V.E.B.); (A.R.G.); (S.V.N.); (R.L.); (A.T.); (A.A.S.); (V.V.F.); (P.V.G.)
- Research Department, Innlandet Hospital Trust, 2380 Brumunddal, Norway
| | - Lyubov N. Chernova
- World-Class Research Center “Digital Biodesign and Personalized Healthcare”, IM Sechenov First Moscow State Medical University (Sechenov University), 119435 Moscow, Russia; (A.V.S.); (P.S.T.); (M.A.); (J.A.); (L.N.C.); (V.E.B.); (A.R.G.); (S.V.N.); (R.L.); (A.T.); (A.A.S.); (V.V.F.); (P.V.G.)
| | - Vladimir E. Belyaev
- World-Class Research Center “Digital Biodesign and Personalized Healthcare”, IM Sechenov First Moscow State Medical University (Sechenov University), 119435 Moscow, Russia; (A.V.S.); (P.S.T.); (M.A.); (J.A.); (L.N.C.); (V.E.B.); (A.R.G.); (S.V.N.); (R.L.); (A.T.); (A.A.S.); (V.V.F.); (P.V.G.)
| | - Andrey R. Grabeklis
- World-Class Research Center “Digital Biodesign and Personalized Healthcare”, IM Sechenov First Moscow State Medical University (Sechenov University), 119435 Moscow, Russia; (A.V.S.); (P.S.T.); (M.A.); (J.A.); (L.N.C.); (V.E.B.); (A.R.G.); (S.V.N.); (R.L.); (A.T.); (A.A.S.); (V.V.F.); (P.V.G.)
| | - Svetlana V. Notova
- World-Class Research Center “Digital Biodesign and Personalized Healthcare”, IM Sechenov First Moscow State Medical University (Sechenov University), 119435 Moscow, Russia; (A.V.S.); (P.S.T.); (M.A.); (J.A.); (L.N.C.); (V.E.B.); (A.R.G.); (S.V.N.); (R.L.); (A.T.); (A.A.S.); (V.V.F.); (P.V.G.)
- Institute of Bioelementology, Orenburg State University, 460018 Orenburg, Russia
| | - Ryszard Lobinski
- World-Class Research Center “Digital Biodesign and Personalized Healthcare”, IM Sechenov First Moscow State Medical University (Sechenov University), 119435 Moscow, Russia; (A.V.S.); (P.S.T.); (M.A.); (J.A.); (L.N.C.); (V.E.B.); (A.R.G.); (S.V.N.); (R.L.); (A.T.); (A.A.S.); (V.V.F.); (P.V.G.)
- l’Institut des Sciences Analytiques et de Physico-chimie pour l’Environnement et les Matériaux, Universite de Pau et des Pays de l’Adour, E2S, CNRS, 64000 Pau, France
| | - Aristides Tsatsakis
- World-Class Research Center “Digital Biodesign and Personalized Healthcare”, IM Sechenov First Moscow State Medical University (Sechenov University), 119435 Moscow, Russia; (A.V.S.); (P.S.T.); (M.A.); (J.A.); (L.N.C.); (V.E.B.); (A.R.G.); (S.V.N.); (R.L.); (A.T.); (A.A.S.); (V.V.F.); (P.V.G.)
- Laboratory of Toxicology, Medical School, University of Crete, Voutes, 70013 Heraklion, Crete, Greece
| | - Andrey A. Svistunov
- World-Class Research Center “Digital Biodesign and Personalized Healthcare”, IM Sechenov First Moscow State Medical University (Sechenov University), 119435 Moscow, Russia; (A.V.S.); (P.S.T.); (M.A.); (J.A.); (L.N.C.); (V.E.B.); (A.R.G.); (S.V.N.); (R.L.); (A.T.); (A.A.S.); (V.V.F.); (P.V.G.)
| | - Victor V. Fomin
- World-Class Research Center “Digital Biodesign and Personalized Healthcare”, IM Sechenov First Moscow State Medical University (Sechenov University), 119435 Moscow, Russia; (A.V.S.); (P.S.T.); (M.A.); (J.A.); (L.N.C.); (V.E.B.); (A.R.G.); (S.V.N.); (R.L.); (A.T.); (A.A.S.); (V.V.F.); (P.V.G.)
| | - Alexey A. Tinkov
- World-Class Research Center “Digital Biodesign and Personalized Healthcare”, IM Sechenov First Moscow State Medical University (Sechenov University), 119435 Moscow, Russia; (A.V.S.); (P.S.T.); (M.A.); (J.A.); (L.N.C.); (V.E.B.); (A.R.G.); (S.V.N.); (R.L.); (A.T.); (A.A.S.); (V.V.F.); (P.V.G.)
- Laboratory of Ecobiomonitoring and Quality Control, Yaroslavl State University, 150003 Yaroslavl, Russia
- Correspondence: ; Tel.: +7-961-937-8198
| | - Peter V. Glybochko
- World-Class Research Center “Digital Biodesign and Personalized Healthcare”, IM Sechenov First Moscow State Medical University (Sechenov University), 119435 Moscow, Russia; (A.V.S.); (P.S.T.); (M.A.); (J.A.); (L.N.C.); (V.E.B.); (A.R.G.); (S.V.N.); (R.L.); (A.T.); (A.A.S.); (V.V.F.); (P.V.G.)
| |
Collapse
|
|
2
|
Anisimov SV, Meshkov AN, Glotov AS, Borisova AL, Balanovsky OP, Belyaev VE, Granstrem OK, Grivtsova LY, Efimenko AY, Pokrovskaya MS, Semenenko TA, Sukhorukov VS, Kaprin AD, Drapkina OM. National Association of Biobanks and Biobanking Specialists: New Community for Promoting Biobanking Ideas and Projects in Russia. Biopreserv Biobank 2020; 19:73-82. [PMID: 33058731 DOI: 10.1089/bio.2020.0049] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
The research biobanking field is developing rapidly in Russia. Over the course of the last decade, numerous biobanks were created or formed from existing collections of human and environmental biospecimens. The Russian National Association of Biobanks and Biobanking Specialists (NASBIO) was established in December 2018, aiming to: (1) unite professionals and research centers to create and develop a network of biobanks in Russia; (2) provide services and expertise in the field of biobanking; (3) execute various research projects utilizing biobanks' infrastructure; and (4) facilitate integration of Russian biomedical research centers into global research activities. The organizational structure, aims, and plans of this newly formed national association are reviewed in this article. The founders of NASBIO hope that the association will promote further development of biobanks and their networking in Russia, which is critically important for the success of national biomedical, pharmaceutical, and biotechnological research, and can facilitate international biobanking projects on a global scale.
Collapse
Affiliation(s)
| | - Alexey N Meshkov
- National Medical Research Center for Therapy and Preventive Medicine, Moscow, Russia
| | - Andrey S Glotov
- D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology, Saint-Petersburg, Russia
| | - Anna L Borisova
- National Medical Research Center for Therapy and Preventive Medicine, Moscow, Russia
| | - Oleg P Balanovsky
- N.I. Vavilov Institute of General Genetics, Research Centre for Medical Genetics, Biobank of North Eurasia, Moscow, Russia
| | - Vladimir E Belyaev
- Biobank, Institute for Regenerative Medicine, I.M. Sechenov First Moscow State Medical University, Moscow, Russia
| | | | | | - Anastasiya Yu Efimenko
- Institute for Regenerative Medicine, Medical Research and Educational Center, M.V. Lomonosov Moscow State University, Moscow, Russia
| | - Maria S Pokrovskaya
- National Medical Research Center for Therapy and Preventive Medicine, Moscow, Russia
| | - Tatyana A Semenenko
- N.F. Gamaleya National Research Center for Epidemiology and Microbiology, Moscow, Russia
| | | | | | - Oxana M Drapkina
- National Medical Research Center for Therapy and Preventive Medicine, Moscow, Russia
| |
Collapse
|